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Antiarrhythmic effects of alpha-adrenoceptor antagonists 
were assessed in the reserpinized guinea pig ventricular 
myocardium. Both bunazosin (1 to 3 x 10-7 M), a new 
alpha}-adrenoceptor antagonist, and yohimbine (1 to 3 x 
10-7 M), another adrenoceptor antagonist, suppressed the 
transient depolarization and triggered activity induced by a 
train of rapid stimuli in the solution containing low potas-
sium ion (K+), high calcium ion (CaH ) and strophanthidin 
(1 to 5 x 10-7 M). Bunazosin (3 x 10-6 M) abolished the 
facilitatory effect of hypoxia on beta-adrenoceptor medi-
ated abnormal automaticity. To clarify the mechanisms 
underlying the antiarrhythmic properties of alpha-adreno-
ceptor antagonists, their electrophysiologic effects on the 
fast and slow action potentials were investigated. 
Alpha-adrenoceptor antagonists (bunazosin, yohimbine 
Adrenergic influence on arrhythmias resulting from myocar-
dial infarction is well recognized (1). A clinical study (2) 
showed that the adrenergic blocking agent phentolamine had 
a prophylactic effect on cardiac arrhythmias in patients with 
acute myocardial infarction. Several investigators (3,4) have 
discussed the role of enhanced alpha-adrenergic responsive-
ness in arrhythmias during myocardial ischemia and reper-
fusion. A recent study (5) demonstrated the involvement of 
alpha- as well as beta-adrenergic effects on worsening of 
arrhythmias in healed myocardial infarction. 
Alpha-adrenergic involvement in arrhythmia in nonische-
mic conditions has also been demonstrated (6-8). The 
alphal-adrenoceptor antagonists AR-C 239 (6) and prazosin 
(7), and the alpha2-adrenoceptor agonist clonidine, reduced 
the arrhythmogenic effect of ouabain, although phenyleph-
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and phentolamine) suppressed the slow response in a dose-
related manner. The voltage-dependent block and use-
dependent block of the maximal rate of rise (V max) of action 
potentials by bunazosin (10-5 to 10-4 M) and yohimbine 
(10-6 to 10-5 M) were studied. The analysis ofthe onset and 
recovery kinetics from the use-dependent block of drugs 
showed that both bunazosin and yohimbine act as slow 
kinetic drugs. 
It is concluded that alpha-adrenoceptor antagonists 
seem to have an antiarrhythmic effect through the inhibi-
tion of fast sodium ion (Na +) and slow CaH currents of Jhe 
cell membrane independently of blockade of myocardial 
alpha-adrenoceptors. 
(J Am Call Cardiol1988;12:1590-8) 
rine and the alpha2-adrenoceptor antagonists yohimbine (7) 
and piperoxan (6) potentiated its arrhythmogenic effect. 
These observations suggested that selective alphal-adreno-
ceptor stimulation and alpha2-adrenoceptor blockade in-
crease the arrhythmogenic effects of ouabain, whereas 
selective alpha2-adrenoceptor stimulation and alpha\-adre-
noceptor blockade inhibit it. Kimura et al. (8) also demon-
strated the suppressive effect of prazosin on catecholamine-
induced delayed afterdepolarizations and triggered activity 
in the presence of elevated calcium ion (Ca2+) levels. 
On the other hand, Mugelli et al. (9) reported that 
yohimbine but not prazosin antagonized norepinephrine-
induced automaticity in hypoxic, glucose-free conditions. 
Moreover, Northover (10) attributed the antiarrhythmic ef-
fect of prazosin, yohimbine, tolazoline, dibenamine and 
phenoxybenzamine to the interaction with the cell mem-
brane and not to inhibition of the alpha-adrenoceptors. 
Despite the findings that prazosin (11,12), urapidil (13), 
bunazosin (14) and yohimbine (12,15,16) reduce the maximal 
rate of rise (V max) of action potentials, somewhat higher 
concentrations of these drugs seem to be necessary to obtain 
the local anesthetic effect on the 'cell membrane compared 
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with the dose required for their alpha-adrenoceptor antago-
nistic effect. Recent models of antiarrhythmic drug interac-
tions with the myocardial sodium ion (Na+) channel (17,18) 
have provided insight into subcellular mechanisms of drug 
action. These basic models have important clinical implica-
tions (19). 
The experiments in this study were carried out to deter-
mine whether alpha-adrenoceptor antagonists have an anti-
arrhythmic effect in guinea pig ventricular myocardium not 
mediated by the inhibition of alpha-adrenoceptors and, if 
they have, whether the mode of action can be explained by 
the model described. 
Methods 
Experimental preparation. Guinea pigs (200 to 300 g) 
were killed by a blow to the head. The papillary muscles (2.5 
to 5 mm long and 0.8 to 1.3 mm in diameter) were rapidly 
excised from the right ventricle and mounted in a tissue bath 
perfused with oxygenated (95% oxygen [02], 5% carbon 
dioxide [C02D Tyrode solution (pH 7.4 ± 0.05) at 36.0 ± 
0.2°e. The flow rate was kept constant at a rate of 3 mllmin 
by using a microtube pump (Tokyo Rikakikai, model MP-3). 
The basal part of the muscle was pinned to a silicon rubber 
floor in the bath by means of bipolar stimulus electrodes 
connected to a stimulator (Nihon Kohden, model SEN-3201) 
through an isolator (Nihon Kohden, model SS-I021). Normal 
Tyrode solution had the following composition (in millimo-
lars): sodium chloride, (NaCl) 132; potassium chloride, 
(KC)) 4; sodium hydrocarbonate, 12; sodium phosphate, 0.4; 
calcium chloride, (CaCI2) 1.8; magnesium chloride, 1 and 
glucose, 10. 
Membrane potentials were measured differentially using 
two microelectrodes filled with 3 M potassium chloride 
(KC!) (resistance 10 to 15 Mil) and led to an amplifier (Nihon 
Kohden, model MEZ-7101). Analog differentiation of the 
action potential was obtained with an electronic differen-
tiator that was linear from 0 to 500 Vis (usual time constant 
10 f-LS, 50 f-LS for slow action potentials). The action potential 
and the maximal rate of rise (V max) of the action potential 
were monitored on an oscilloscope (Nihon Kohden, model 
VC-IO), photographed by a camera (Nihon Kohden, model 
RLG-6201) and recorded simultaneously on a chart recorder 
(Nih on Kohden, model RJG-4122). The muscles were stim-
ulated at a rate of 1 Hz (voltage 1.5 times threshold, duration 
2 ms) during the period of equilibration after mounting and 
during analysis of the steady state effect of drugs. Stimula-
tion rate and mode were varied for each protocol. 
Slow action potential. The high K+ solution for induction 
of the slow response contained 27 instead of 4 mM KCI and 
0.2 mM barium chloride (BaCI2) in the normal Tyrode 
solution. The effect of drugs on the facilitatory effect of 
hypoxia in beta-adrenoceptor agonist-induced abnormal 
membrane responses was examined using our recently re-
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ported method (20). Hypoxia was induced by bubbling the 
solution with 95% nitrogen (N2) and 5% CO2 instead of the 
mixture of 95% O2 and 5% CO2, Measurements of respon-
siveness were repeated during control (normoxia) and during 
hypoxia at around 1 h after its induction. 
Transient depolarization. For induction of transient de-
polarization of the membrane potential the concentrations of 
KCI and CaCl2 in the normal Tyrode solution were changed 
to 0.5 and 3.6 mM, respectively, and 1 to 5 X 10-7 M 
strophanthidin was added. In each solution after 10 min of 
equilibration, 1, 1.5, 2, 2.5 and 3 Hz stimulation for 10 s was 
applied. 
Use-dependent block. The use-dependent block of V max 
was measured by a procedure similar to that already re-
ported (21-29). The preparation was stimulated at rates of 
0.2, I, 2 and 3 Hz for 30 to 60 s. These trains of stimuli were 
applied after every rest period of 90 s, which was sufficient 
for recovery from the use-dependent decrease in V max' The 
amount of use-dependent block was defined as percent 
decrease of V max from the value of first action potential to 
the steady state level, and that of tonic block as percent 
decrease of V max from the value of first action potential in 
control to that in the presence of a drug. For analysis of 
recovery kinetics from drug action, the preparation was 
stimulated with a rapid (2 Hz) train of impulses for 30 s after 
a 90 s rest period. Stimulation was then terminated and an 
extrastimulus was applied. The coupling intervals after ter-
mination of the trains were progressively increased from 0.5 
to 1, 3, 5, 10,20 and 30 s. 
Voltage-dependent block. To study the relation between 
membrane potential and V max' the membrane was depolar-
ized by varying the concentration of KCI in Tyrode solution 
from 2.7 to 5.4,8.1, 10.8, 13.5 and 14.9 mM. Stimulation was 
applied at 0.2 Hz. The following equation proposed by 
Windisch and Tritthart (30) was used to obtain the curve 
fitting the experimental values: 
"max = Vs/(l + exp [( Em - ED IS 1 f, 
where Em = membrane potential, Vs, Ef and S represent the 
saturation value (maximal value) of V max' the membrane 
potential at which V max is 25% of V s and the slope factor, 
respectively. These values were obtained by the least 
squares method. The validity of this method to show the 
V max-membrane potential relation of guinea pig ventricular 
muscle has been verified (31,32). 
Drugs. The following drugs were added to the solution 
just before each experiment: bunazosin hydrochloride 
(Eisai), yohimbine hydrochloride (Sigma), phentolamine 
mesylate (Ciba-Geigy), I-isoproterenol hydrochloride 
(Nikken) and strophanthidin (Sigma). To avoid interference 
of endogenous norepinephrine, the catecholamine content in 
the heart was lowered by pretreating the guinea pigs subcu-
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Figure 1. The suppression of transient depolarizations by bunazo-
sin and yohimbine. A, Membrane potential in high gain during fast 
drives in Tyrode solution (Control), strophanthidin-containing test 
solution (0.5 mM potassium [K], 3.6 mM calcium [Ca], strophanthi-
din [Strj) and in the presence ofbunazosin (Buna) in the test solution 
(+ 10-7 M Buna and +3 x 10-7 M Buna). Stimuli were applied at 
frequencies of 0.5, 1, 1.5, 2.5 and 3 Hz as indicated next to the 
control traces. Arrows indicate the transient depolarizations induced 
by the test solution. B, The same procedure as in A was applied in 
the presence of yohimbine (Yoh) instead of bunazosin. In all traces, 
only the lower part of the action potentials are shown except for the 
inset ofB. In the inset, action potentials induced by 2.5 Hz electrical 
stimuli and triggered activities in strophanthidin-containing test 
solution are shown at low gain. 
taneously with 2.5 mg/kg reserpine (Daiichi) 1 day before 
they were killed. 
Statistics. All experimental results were obtained from a 
single continuous impalement throughout the experiment. 
Values are given as mean values ± SEM. Statistical analysis 
was performed by the Student's t test. 
Results 
Effect of alpha-adrenoceptor antagonists on the transient 
depolarization induced by low K+, high Ca2+ plus strophan-
thidin (Fig. 1). Figure 1 shows the membrane potentials of 
muscles during and after fast drives. Fast drives for 10 s 
were applied in normal Tyrode solution (controi), in the 
strophanthidin-containing test solution (0.5 roM K +,3.6 roM 
Ca2+, with 1 to 5 X 10-7 M strophanthidin) and in the 
presence of therapeutic concentrations of bunazosin or 
yohimbine in the test solution. In the test solution, the fast 
drives of the same frequencies were followed by a transient 
depolarization. In the presence of bunazosin or yohimbine, 
the amplitude of the transient depolarization was dimin-
ished. Similar results were obtained in four experiments for 
bunazosin and three for yohimbine. 
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Figure 2. Bunazosin-induced inhibition of the facilitation of the 
beta-adrenoceptor-mediated abnormal automaticity by hypoxia. A, 
Two-step membrane responses to catecholamine (isoproterenol) for 
the evaluation of its arrhythmogenic potential. Thin horizontal bars 
under each potential trace indicate the period of isoproterenol 
application. At low concentrations, isoproterenol failed to affect the 
membrane potential (a). Concentrations (conc.) of isoproterenol 
needed for depolarization of membrane (b) and for automatic 
repetitive action potentials preceded by rapid depolarization (c) 
were taken as a basis for comparison. Isoproterenol-induced repet-
itive action potentials as shown by oscilloscope appear in d. B, 
Concentrations of isoproterenol for depolarization (circles) and for 
automaticity (squares) under normal (N on the abscissa) and hypoxic 
conditions (H) in control (solid symbols) and in the presence of 3 x 
10 - 5 M bunazosin (open symbols) are plotted. Each point is the mean 
value of five experiments in a and three experiments in b; vertical 
bars are SEM. *p < 0.05. 
Effect of bunazosin on the beta-adrenoceptor-mediated 
abnormal automaticity during hypoxia (Fig. 2). Responsive-
ness of muscle cells to beta-adrenoceptor agonist was eval-
uated from the concentrations of isoproterenol required for 
membrane depolarization alone and for automatic repetitive 
action potentials preceded by rapid depolarization (Fig. 2A). 
In the hypoxic condition (Fig. 2B) the responsiveness be-
came higher than the control value, although in normal 
conditions repetitive trials did not alter the responsiveness of 
the preparation, as previously reported (33). In the presence 
of 3 x 10-6 M bunazosin, hypoxia failed to increase the 
responsiveness of muscle cells. 
Effects of alpha-adrenoceptor antagonists on the slow ac-
tion potentials (Fig. 3 and 4). Because in catecholamine-
induced membrane depolarization the beta-adrenoceptor-
mediated increase in the slow inward current plays an 
important role (34), the effect of the alpha-adrenoceptor 
antagonists bunazosin, yohimbine and phentolamine on the 
Ca2+ -mediated slow response was studied. At bunazosin 
concentrations> 10-5 M, slow action potentials showed a 
slow V max' reduced amplitude of overshoot and prolonged 
duration. Yohimbine reduced V max and overshoot in a 
dose-dependent manner even at low concentrations (Fig. 4). 
Phentolamine, a nonselective alpha-adrenoceptor antago-
nist, suppressed the slow action potentials at relatively high 
concentrations (not shown). 
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Figure 3. Effect of bunazosin on the slow action potential. A, 
Action potential and its maximal rate of rise (V maJ in control (a), in 
the presence of 10-6 (b), 10-5 (C), 3 X 10-5 (d), 10-4 (e) and 3 x 10-4 
M (0 bunazosin. B, Dose-response relation for the effect of buna-
zosin on variables of the slow action potential. Each point repre-
sents the mean value and vertical bars are the SEM of five experi-
ments. *p < 0.05; **p < 0.01; APD = action potential duration; OS 
= amplitude of overshoot of action potential. 
Effects of a1pha-adrenoceptor antagonists on the steady 
state normal action potentials stimulated at 1 Hz (Table 1). 
Bunazosin decreased V max and overshoot of action poten-
tials in a dose-related manner. Simultaneous recording of 
muscle contractile force showed the reduction of force at 
increased bunazosin concentrations (not shown). 
A 
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Use-dependent effect of alpha-adrenoceptor antagonists on 
V max (Fig. 5 and 6). After the tonic block of V max induced by 
bunazosin, further decline of V max to a new steady state 
(use-dependent block) during the train of stimuli depended 
on the stimulation frequency (Fig. 5A). Development kinet-
ics of use-dependent block at different stimulation rates can 
be defined in terms of either a time-dependent or an event-
dependent process. In both cases, development kinetics 
represented a function of the interstimulus interval in that 
time constant and rate constant decreased with increasing 
stimulation rate. In the presence of to-4 M bunazosin, time 
constants of onset of use-dependent block for 0.2, 1, 2 and 3 
Hz stimulation were 14.25 ± 1.13, 6.43 ± 0.78, 4.02 ± 0.83 
and 2.76 ± 0.71 s (n = 4), respectively. There was a distinct 
relation between bunazosin-induced use-dependent V max 
block and interstimulus interval (Fig. 5B). Dose-response 
relation of tonic- and use-dependent inhibition of V max by 
bunazosin was determined. The use-dependent V max inhibi-
tion appeared in a lower concentration range than for tonic 
block. 
To investigate the rest recovery process from use-
dependent block of it max induced by bunazosin, a single 
extrastimulus was applied after cessation of each train of 2 
Hz stimulation. In Figure 5C, the influence of concentration 
of bunazosin on the recovery kinetics of use-dependent 
block is also demonstrated. The mean recovery time con-
stant from the use-dependent block for five experiments was 
18.41 ± 2.85 s (n = 5) for 10-4 M, 19.30 ± 2.63 s (n = 3) for 
3 x 10-5 and 27.56 ± 3.94 s (n = 3) for 10-5 M bunazosin. 
Rapid stimulation caused the membrane depolarization 
that might lead to a transient decrease in it max' In the 
control state, only a small decrease in V max was observed 
even when the diastolic potential was reduced by about 5 
mV (peaked within 30 s). In the presence of to-5, 3 x 10-5 
and 10-4 M bunazosin, further reductions in V max were 
Figure 4. Effect of yohimbine on the slow action poten-
tial. Action potentials in A were recorded in control (a) 
and in the presence of 10-6 (b), 10-4 (c) and 3 x 10-4 (d) 
M yohimbine. Dose-response relations are shown in B to 
D (six experiments) *p < 0.05, **p < 0.01. Abbrevia-
tions as in Figure 3. 
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Table 1. Effect of Bunazosin on the Variables of Steady State Action Potentials in Tyrode 
Solution (n = 3) 
Bunazosin 
Concentration 
(M) V max (Vis) OS (mV) RP(-mV) APD (ms) 
Control 228.7 ± 1003 40.0 ± 2.6 89.3 ± 1.5 22203 ± 2.3 
10-7 228.7 ± 1003 40.7 ± 2.2 88.7 ± 1.9 21603 ± 3.5 
10-6 224.0 ± 14.0 40.7 ± 2.2 89.3 ± 0.7 217.0 ± 2.1* 
10-5 194.3 ± 17.6* 39.3 ± 1.9 89.3 ± OJ 224.7 ± 7.4 
3 x 10-5 160.0 ± Il.5t 39.3 ± 1.9 88.7 ± 0.7 227.3 ± 11.2 
10-4 121.3 ± 22.6* 37.7 ± 2.2* 87.3 ± 1.2 234.7 ± 7.4 
3 x 10-4 60.0 ± 7.6t 32.0 ± 3.5* 87.3 ± 1.3 234.7 ± 12.3 
*p < 0.05; tp < 0.01. APD = action potential duration measured at 90% repolarization level; OS = amplitude of 
overshoot of action potential; RP = potential at rest; V max = maximal rate of rise of action potential. Data are mean 
± SEM. 
observed although depolarization caused by rapid stimula-
tion was similar to the control value. 
Use-dependent block in V max induced by yohimbine was 
also investigated (Fig. 6A), as well as the recovery kinetics 
of use-dependent block for yohimbine (Fig. 6B). The mean 
value of recovery time constant in the presence of 10-5 M 
yohimbine for two experiments was 20.8 s. 
Voltage-dependent effect of alpha-adrenoceptor antagonists 
on V max (Fig. 7). The effect of 3 x 10-5 M bunazosin on the 
V max-membrane potential relation was examined by chang-
ing the K + concentration of Tyrode solution to alter the 
membrane potential. V max and membrane potential were 
measured during a steady state at each K+ concentration in 
four preparations, and the mean value was normalized (Fig. 
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7 A). The smooth curves were drawn by computer according 
to the equation of Windisch and Tritthart (30). Bunazosin 
shifted the normalized V max by 17.7 m V to a more negative 
potential so that half-inactivation appeared at -79.4 mY. 
The effect of yohimbine on the V max-membrane potential 
relation was also examined in two preparations in a similar 
manner (Fig. 7B). 
Discussion 
Effect of alpha-adrenoceptor antagonists on the transient 
depolarization induced by low K+, high Ca2+ plus strophan-
thidin. The present study demonstrates that strophanthidin-
induced transient depolarization is suppressed by bunazosin, 
Figure 5. Use-dependent maximal rate of rise of action 
potential (V max) inhibition by bunazosin. A, Bunazosin 
(3 x 10-5 M)-induced V max inhibition at a stimulation 
rate of 0.2 Hz (filled circles), 1 Hz (open circles), 2 Hz 
(open triangles) and 3 Hz (filled triangles). B, The depen-
dence of bunazosin-induced use-dependent V max block 
on interstimulus interval. Each value represents the 
mean of four experiments. Filled circles show the values 
in the presence of 10-5 M bunazosin and open circles 
show 10-4 M. C, Effects of bunazosin concentration on 
recovery kinetics from use-dependent block of V max' 
The time course of V max recovery was plotted against 
the coupling interval of a single stimulus after cessation 
of 2 Hz train stimuli. Filled circles (T = 26.0 s), open 
circles (T = 18.6 s) and filled squares (T = 14.0 s) 
represent values in the presence of 10-5, 3 x 10-5 and 
10-4 M bunazosin, respectively. Inset, recording from 
one experiment illustrating protocol. Vertical calibra-
tion 200 Vis. 
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Figure 6. Use-dependent maximal rate of rise of action potential 
(V max) inhibition by yohimbine. A, Yohimbine (10-5 M)-induced 
V max inhibition at a stimulation rate of 0.2 Hz (filled circles), 1 Hz 
(open circles), 2 Hz (open trjangles) and 3 Hz (filled triangles). B, 
Recovery kinetics from 10-5 M yohimbine-induced use-dependent 
block. The time course of V max recovery plotted against the coupling 
interval of a single extrastimulus after termination of 2 Hz train 
stimuli. 
a new selective alpha1-adrenoceptor antagonist, and by 
yohimbine, which is reported to preferentially block alpha2-
adrenoceptors. Previous studies (6,7) on the effects of alpha-
adrenoceptor antagonists on ouabain-induced arrhythmia 
showed that selective alpha)-adrenoceptor blockade inhib-
ited the arrhythmia whereas alpha2-adrenoceptor blockade 
increased it. These experiments were performed in anesthe-
tized guinea pigs in which the adrenergic system was intact. 
In the present study, guinea pigs were pretreated with 
reserpine to lower the catecholamine content of the prepa-
rations, and ventricular papillary muscles perfused with 
Tyrode solution were used without any application of cate-
cholamines. The discrepancies in the results with yohimbine 
may be attributable to these differences in preparation and 
condition. In nonreserpinized animals with intact adrenal 
glands, alpha2-adrenoceptor antagonism may increase the 
alpha1-adrenergic tone, and the arrhythmogenic effect of 
such alpha)-adrenoceptor stimulation might mask the anti-
arrhythmic effect of yohimbine. The present observations 
may be ascribed to the direct effect of drugs on muscle cells. 
Role in ventricular arrhythmias. The proposed mecha-
nisms responsible for ventricular arrhythmias, especially 
during myocardial ischemia, are 1) reentrant excitation; 2) 
automaticity; and 3) some combination of these two mech-
anisms (35). A recent study (36) to delineate the mechanisms 
for arrhythmias associated with reperfusion of ischemic 
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Figure 7. Effect of alpha-adrenoceptor antagonists on the relation 
between maximal rate of rise of action potential (V max) and mem-
brane potential at rest (Em) at different potassium (K+) concentra-
tions. A, Effect of3 x 10-5 Mbunazosin on the V max-Em relation (a) 
and on the normalized V max-Em curve (b). Each value represents 
the mean offour experiments. B, Effect of 10-5 M yohimbine on the 
V max-Em relation (a) and on the normalized V max-Em curve (b). 
Filled circles represent control values and open circles indicate 
values in the presence of bunazosin (A) or yohimbine (B). See text. 
myocardium demonstrated that ventricular arrhythmia was 
most commonly initiated by a nonreentrant mechanism that 
might involve an abnormal form of automaticity or triggered 
activity. Kimura et a1. (5) described the tendency to trig-
gered activity of cat Purkinje fibers after healing of myocar-
dial infarction. Triggered activity induced by norepinephrine 
in hypoxic glucose-free conditions was recently demon-
strated to be suppressed by yohimbine (9). This finding is 
consistent with the depressant effect of yohimbine in the 
present study. 
The transient depolarization resulting in triggered activity 
is exaggerated by conditions that increase cellular Ca2+ 
content, such as high Ca2+, low Na+ solution and low 
concentrations of caffeine (37-40). The transient depolariza-
tion reflects the transient inward current resulting from an 
oscillatory release of Ca2+ from the Ca2+ -overloaded sarco-
plasmic reticulum (41). Because this current depends on the 
cellular Ca2+ load to some extent (41,42), interventions to 
reduce the Ca2+ load to the cells, such as applications of 
slow channel blocking agents, diminish it (41). Furthermore, 
local anesthetic agents have been shown (43) to depress the 
strophanthidin-induced transient depolarization through a 
decreasing intracellular N a + and therefore intracellular 
Ca2+. The suppression not only of the Ca2+ current but also 
of the Na + current shown in the present study may explain 
the depressant effect on the transient depolarization induced 
by alpha-adrenoceptor antagonists. 
Effect of bunazosin on beta-adrenoceptor-mediated abnor-
mal automaticity during hypoxia. Abnormal automaticity is 
another potential nonreentrant mechanism of arrhythmias. 
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Abnormal automatiCity occurs under specific conditions 
such as with the application of a depolarizing current pulse 
(44,45) and exposure to catecholamine in Ba2+ -containing 
high K + solution (34,46), not only in Purkinje fibers, but also 
in ventricular muscle. The facilitatory effect of hypoxia on 
beta-adrenoceptor- and slow channel-mediated abnormal 
automaticity (33) was shown to be inhibited by application of 
bunazosin in our present study. Because no alpha-
adrenoceptor agonists were contained in the solution, this 
depressant effect of bunazosin on automaticity may result 
from the blocking effect of Ca2+ current, which plays a 
major role in the initiation of action potentials in high K + 
solutions (34,47). 
The depressant effects of alpha-adrenoceptor antagonists 
on the slow Ca2+ current were then tested (Fig. 3 and 4). 
Azuma et al. (15) found that at 10-5 to 10-4 M, yohimbine 
enhanced the isoproterenol-induced slow action potentials in 
a few cases but lowered the mean values of V max and 
amplitude of slow action potentials. In the present study, 
yohimbine in low concentrations produced no augmentation 
of slow response but a significant decrease in V max and 
overshoot. These differences may be derived from the 
choice of method to induce the slow response in high K + or 
tetrodotoxin-containing solutions. The finding that bunazo-
sin suppressed the slow response is compatible with the 
observation in voltage clamp experiments on the rabbit sinus 
node (14). 
These observations that not only an alpha]-adrenoceptor 
antagonist but also an alpha2-adrenoceptor antagonist and a 
nonselective alpha-adrenoceptor antagonist suppressed the 
slow channel of myocardial cells suggest that the slow 
channel blocking effect of alpha-adrenoceptor antagonists 
may contribute to their antiarrhythmic effect. 
Use-dependeJlt and voltage-dependent effect of alpha-
adrenoceptor aqtagonists on V max of fast action potentials. 
The fast Na + channel blocking effect (local anesthetic effect) 
of alpha-adrenoceptor antagonists was also elucidated in this 
study. Previous studies showed that V max of steady state 
action potentials of Purkinje fiber or ventricular muscle cell 
is suppressed by prazosin (11,12), phentolamine (10,48), 
yohimbine (12,15,16) and urapidil, a new alpha]-adreno-
ceptor antagonist (13). In these studies, use dependency (10) 
and voltage dependency (48) of the phentolamine action 
were observed. In the present study the kinetics of use-
dependent block and voltage-dependent block of V max of 
action potentials for bunazosin and for yohimbine were 
examined. The characteristics of the use-dependent inhibi-
tion of V max induced by either bunazosin or yohimbine are 
similar to those of slow kinetic drugs such as disopyramide 
rather than to the characteristics of fast ones, according to 
the classification proposed by Courtney (26). 
Class I antiarrhythmic drugs have been classified into 
two or three subclasses from their use-dependent kinetics, 
and their characteristics predicted based on their molecular 
JACC Vol. ]2, No.6 
December 1988: 1590-8 
weight, pKa (the dissociation constant) and log P (the log of 
the n-octanol, water partition coefficient) (25-29,49,50). 
Analysis of V max inhibition based on the modulated receptor 
theory (17) and structural characteristics has been shown to 
be applicable (51) not only for antiarrhythmic drugs but also 
for other chemicals such as beta-adrenoceptor antagonists. 
The pKa for bunazosin is 7.7. Bunazosin (373.4) and yohim-
bine (354.4) have a much larger molecular weight than that of 
quinidine (324.4) or disopyramide (339). The molecular size 
may be related to the slow recovery kinetics of these drugs. 
Previous studies (25-27 ,50,52) indicate that the rate of onset 
of use-dependent block is directly correlated with molecular 
weight, but not with lipid solubility, and increases with 
increasing drug concentration. The studies of recovery of 
V max from block (26,49,50) show a good direct correlation 
between molecular weight and recovery times of V max' Our 
present results are compatible with these observations. 
Clinical implications. Alpha-adrenoceptor antagonists 
have been reported to be effective in preventing cardiac 
arrhythmia in patients with myocardial infarction (2). During 
myocardial ischemia, loss of K + from myocardium and 
extracellular K + accumulation occurs (53). In th!(se condi-
tions, membrane depolarization due to increased extracellu-
lar K + might exaggerate the voltage-dependent inhibition of 
Na + channel by alpha-adrenoceptor antagonists. Because 
alpha-adrenergic stimulation causes a restoration of the slow 
response (54) and increases the Ca2+ load of the cell (55-57), 
the increase of serum catecholamine concentration and the 
enhanced a,lpha-adrenergic responsiveness during myocar-
dial ischemia (3) may facilitate the arrhythmogenicity in-
duced by Ca2+ overload of the myocardial cells. Indeed, the 
alpha-adrenoceptor antagonistic effect of drugs seems to 
prevent arrhythmias mainly in such conditions, but the 
suppression of fast Na + and slow Ca2+ currents induced by 
alpha-adrenoceptor antagonists might exert an additional 
role in their antiarrhythmic action. 
Conclusions. This study demonstrates that alpha-adre-
noceptor antagonists have an antiarrhythmic effect, espe-
cially in the arrhythmia induced by abnormal automaticity or 
triggered activity, probably through the inhibition of fast 
Na + and slow Ca + currents independently of blockade of 
cardiac alpha-adrenoceptors. The changes in V max and im-
pulse conduction velocity produced by local anesthetics 
have been shown to correlate well and this relation has been 
recognized to be useful in applying the known effects of 
drugs on V max to impulse propagation (58-60). Therefore, 
the depressant effect of alpha-adrenoceptor antagonists on 
the slow and fast action potentials demonstrated in the 
present study may suppress reentrant type arrhythmia. 
We appreciate the assistance of Mihoko Doso and Nobuko Abe in preparation 
of the manuscript. 
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